Tae Oh Kim

Tae Oh Kim

Auto-generated profile, based on publicly available information

Tae Oh Kim

Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine , 88, Olympic-Ro 43-Gil, Songpa-gu, Seoul 05505

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
DKDo-Yoon Kang
Do-Yoon Kang
JAJung-Min Ahn
Jung-Min Ahn
SYSung-Cheol Yun
Sung-Cheol Yun
HPHanbit Park
Hanbit Park
SCSang-Cheol Cho
Sang-Cheol Cho
SPSeung-Jung Park
Seung-Jung Park
Background: Compared with angiographic guidance, intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) is associated with better clinical outcomes. However, its very long-term clinical effect is still unclear in patients undergoing PCI for unprotected left main coronary artery disease. Methods: To compare 10-year outcomes of IVUS-guided versus angiography-guided PCI for left main coronary artery disease, we evaluated 975 patients who underwent unprotected left main coronary artery PCI between January 2000 and June 2006 from the MAIN-COMPARE (The Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. The 10-year rates of clinical outcomes (death; the composite of death, Q-wave myocardial infarction [MI], or stroke; and target-vessel revascularization) were compared between IVUS guidance and angiography guidance. Adjusted analyses were performed with the use of inverse-probability-treatment-weighting and propensity score matching. Results: Among the 975 patients, 756 (77.5%) had IVUS guidance. The observed 10-year incidence rate of death (16.4% versus 31.0%, P <0.001) and composite of death, Q-wave MI, or stroke (19.2% versus 32.9%, P <0.001) was significantly lower in the IVUS-guided than in the angiography-guided group. The 10-year incidence rate of target-vessel revascularization was similar between the 2 groups (21.8% versus 18.3%, P =0.41). After adjusting for potential confounders with inverse-probability-treatment-weighting, IVUS was associated with lower incidence of mortality (hazard ratio, 0.75 [95% CI, 0.55–1.03]; P =0.07) and composite of death, Q-wave MI, or stroke (hazard ratio, 0.79 [95% CI, 0.59–1.06]; P =0.11). In 208 propensity score–matched pairs, IVUS was also associated with lower incidence of death (hazard ratio, 0.73 [95% CI, 0.53–1.02]; P =0.07) and composite outcome of death, Q-wave MI, or stroke (hazard ratio, 0.71 [95% CI, 0.52–0.97]; P =0.03). The benefit of IVUS-guided PCI was consistent in the various subsets of clinical and anatomic characteristics. Conclusions: In patients undergoing PCI for unprotected left main coronary artery disease, IVUS-guided PCI compared with angiography-guided PCI was associated with lower long-term (10-year) risks of morality and composite of death, Q-wave MI, or stroke. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02791412.

1 January 2022 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
YYYoung Won Yoon Young Won Yoon
Young Won Yoon Young Won Yoon
SHSangwon Han
Sangwon Han
Osung KwonOsung Kwon
Osung Kwon
KLKyusup Lee
Kyusup Lee
JKJu Hyeon Kim
Ju Hyeon Kim
SLSeung-Whan Lee
Seung-Whan Lee
Korean Circulation Journal 대한심장학회지 순환기 Yoon YH, et al. Korean Circ J. 2021 Nov;52:e5. https://doi.org/10.4070/kcj.2021.0240

15 February 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
YYYujin Yang
Yujin Yang
JAJung‐Min Ahn
Jung‐Min Ahn
DKDo‐Yoon Kang
Do‐Yoon Kang
EKEuihong Ko
Euihong Ko
SKSeonok Kim
Seonok Kim
DPDuk‐Woo Park
Duk‐Woo Park
Background: Various ECG criteria for left ventricular hypertrophy (LVH) have been proposed, but their association with clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement is unknown. We investigated the prevalence of ECG LVH according to different criteria and its prognostic impact on clinical outcomes after transcatheter aortic valve replacement. Methods and Results: In this prospective observational cohort, we evaluated 700 patients who underwent transcatheter aortic valve replacement between March 2010 and December 2019. Baseline preprocedural LVH was defined by 3 ECG criteria—Sokolow‐Lyon, Romhilt‐Estes, and Cornell voltage criteria. The primary outcome was major adverse cardiac or cerebrovascular event (MACCE; composite of death, myocardial infarction, stroke, or rehospitalization from cardiovascular cause); the key secondary outcome was all‐cause and cardiovascular mortality. Among 596 eligible patients, the prevalence of LVH was determined as 56.3% by Sokolow‐Lyon, 31.1% by Romhilt‐Estes, and 48.1% by Cornell criteria. Regardless of the criteria, patients with ECG LVH had more severe aortic stenosis hemodynamics and higher left ventricular mass index. After multivariate adjustment, the presence of LVH by the Cornell criteria was significantly associated with lower risks of MACCE (adjusted hazard ratio [HR], 0.68; 95% CI, 0.51–0.91; P =0.009), all‐cause mortality (adjusted HR, 0.55; 95% CI, 0.34–0.90 [ P =0.017]), and cardiovascular mortality (adjusted HR, 0.40; 95% CI, 0.20–0.79 [ P =0.008]). However, this association was absent with the Sokolow‐Lyon and Romhilt‐Estes criteria. Conclusions: ECG LVH by Cornell criteria only was significantly associated with lower risks of MACCE and all‐cause or cardiovascular mortality. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03298178.

19 October 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
JLJong‐Young Lee
Jong‐Young Lee
SLSeung-Whan Lee
Seung-Whan Lee
TKTae Oh Kim
Tae Oh Kim
YYYujin Yang
Yujin Yang
YJYeong Jin Jeong
Yeong Jin Jeong
SPSeong‐Wook Park
Seong‐Wook Park
Background: The long‐term impact of newly discovered, asymptomatic abnormal ankle–brachial index (ABI) in patients with significant coronary artery disease is limited. Methods and Results: Between January 2006 and December 2009, ABI was evaluated in 2424 consecutive patients with no history of claudication or peripheral artery disease who had significant coronary artery disease. We previously reported a 3‐year result; therefore, the follow‐up period was extended. The primary end point was a composite of all‐cause death, myocardial infarction (MI), and stroke over 7 years. Of the 2424 patients with significant coronary artery disease, 385 had an abnormal ABI (ABI ≤0.9 or ≥1.4). During the follow‐up period, the rate of the primary outcome was significantly higher in the abnormal ABI group than in the normal ABI group ( P <0.001). The abnormal ABI group had a significantly higher risk of composite of all‐cause death/MI/stroke than the normal ABI group, after adjustment with multivariable Cox proportional hazards regression analysis (hazard ratio [HR], 2.07; 95% CI, 1.67–2.57; P <0.001) and propensity score–matched analysis (HR, 1.97; 95% CI, 1.49–2.60; P <0.001). In addition, an abnormal ABI was associated with a higher risk of all‐cause death, MI, and stroke, but not repeat revascularization. Conclusions: Among patients with significant coronary artery disease, asymptomatic abnormal ABI was associated with sustained and increased incidence of composite of all‐cause death/MI/stroke, all‐cause death, MI, and stroke during extended follow‐up over 7 years.

5 March 2025 in JACC: Case Reports
Verified
Journal Article
Open access
HJHa Hye Jo
Ha Hye Jo
SLSo-Min Lim
So-Min Lim
DPDayoung Pack
Dayoung Pack
TKTae Oh Kim
Tae Oh Kim
SLSahmin Lee
Sahmin Lee
JSJae-Kwan Song
Jae-Kwan Song
Hemodynamically significant left ventricular outflow tract obstruction is a rare complication of transcatheter aortic valve implantation (TAVI). This study presents an unusual case of a patient who, after a successful TAVI, developed and experienced progressive worsening of severe left ventricular outflow tract obstruction after uneventful TAVI that was effectively relieved using mavacamten.

1 January 2025 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
EKEun Kyoung Kim
Eun Kyoung Kim
MCMin-Ku Chon
Min-Ku Chon
HKHyun-Sook Kim
Hyun-Sook Kim
YPYong Hyun Park
Yong Hyun Park
SLSang Hyun Lee
Sang Hyun Lee
JHJoo-Yong Hahn
Joo-Yong Hahn
Kim EK, et al. Korean Circ J. 2024 Oct;55:e1. https://doi.org/10.4070/kcj.2024.0147